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In vitro -glucosidase inhibition assays and ultrafiltration liquid chromatography with photo-
diode array detection coupled to electrospray ionization tandem mass spectrometry
(ultrafiltration LC-DAD-ESI-MSn) were combined to screen -glucosidase inhibitors from
hawthorn leaf flavonoids extract (HLFE). As a result, four compounds were identified as
-glucosidase inhibitors in the HLFE, and their structures were confirmed to be quercetin-3-O-rha-
(1-4)-glc-rha and C-glycosylflavones (vitexin-2“-O-glucoside, vitexin-2”-O-rhamnoside and vi-
texin) by high-resolution sustained off resonance irradiation collision-induced dissociation
(SORI-CID) data obtained by Fourier transform ion cyclotron resonance mass spectrometry
(FTICR MS). Several other C-glycosylflavones (vitexin, isovitexin, orientin, isooriention)
and their aglycones apigenin and luteolin were evaluated by in vitro assays, and were
found to possess strong -glucosidase inhibitory activities as well. Moreover, the substitu-
ent groups on the flavones had a great impact on the enzyme inhibition activity. C-3=-OH
of the B-ring of flavones in particular increased the -glucosidase inhibition activity,
whereas C-glycosylations at C-6 or C-8 of the A ring weakened the inhibition activity. (J Am Soc
Mass Spectrom 2009, 20, 1496–1503) © 2009 American Society for Mass SpectrometryType 2 diabetes mellitus has been recognized as aserious global health problem, often resulting insubstantial morbidity and mortality. -Glucosidase
inhibitors are usually used in the treatment of type 2
diabetes mellitus. They act by a reversible inhibition
of -glucosidase, an enzyme present in the brush
border of the small intestine. The inhibition of intes-
tinal -glucosidases could delay the digestion and ab-
sorption of carbohydrates and, consequently, suppress
postprandial hyperglycemia [1]. Although strong syn-
thetic -glucosidase inhibitors (i.e., acarbose) are avail-
able, they usually cause significantly adverse gastroin-
testinal events [2]. For this reason, naturally occurring
-glucosidase inhibitors, particularly those from the Chi-
nese herbal medicines, have been explored as viable, low
toxicity alternatives for treating type 2 diabetes mellitus.
More than 100 herbal medicines have been reported to
show great potency in inhibiting the -glucosidase activity
and equivalent efficacies to synthetic drugs in managing
diabetes [3–5].
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doi:10.1016/j.jasms.2009.04.003Flavonoids are a group of natural polyphenolic de-
rivatives and are ubiquitous in fruits, vegetables, and
traditional Chinese herbal medicines. For centuries,
preparations containing flavonoids as the principal
physiologically active constituents have been used to
treat human diseases [6]. Some of such flavonoid-
containing preparations have been shown to have sig-
nificant effects on diabetes and diabetic syndromes by
the following mechanisms: antioxidant activity [7],
-glucosidase inhibitory effect [8], and insulin-like ef-
fect [9]. In addition, flavonoids have also been found to
have antiplatelet aggregation and aldose reductase in-
hibitory activities, which may have helped to reduce the
severity of the diabetic syndrome [10, 11].
Hawthorn (Crataegus oxyacantha L.) is a traditional
medicinal plant, and its leaf has been used as a tradi-
tional medicine to treat irregular heartbeat, high blood
pressure, chest pain, hardening of the arteries, and
congestive heart failure. Hawthorn leaf extracts contain
different subgroups of flavonoids, including flavones
and flavonols. So far, more than 60 flavonoids have been
isolated and identified from hawthorn, which are mainly
derivatives of (1) apigenin, (2) luteolin, (3) kaempferol, (4)
quercetin, and (5) naringin [12]. These compounds have
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1497J Am Soc Mass Spectrom 2009, 20, 1496–1503 -GLUCOSIDASE BY ULTRAFILTRATION LC-DAD-MSnlipid-lowering, antioxidant, anti-inflammatory and LDL
oxidation inhibitory properties, and protective effect
against diabetes [13]. Recent studies have also shown that
the intake of certain types of flavonoids, including quer-
cetin and myricetin is inversely associated with the risk of
incident type 2 diabetes [14]. Isoquercitrin, isorhamnetine-
3-O-rutinoside, and vitexin have shown inhibitory activi-
ties on -glucosidase from the rat intestine [15].
Hawthorn leaf flavonoids extracts (HLFE) have been
widely studied for their roles in preventing lipid disor-
der, treatment of heart failure, and lowering blood
pressure, using either bioassays or instrumental analy-
sis such as LC/MS [16–20]. However, the inhibitory
effect of hawthorn leaf flavonoids on -glucosidase activ-
ity has not been evaluated by either of these twomethods.
Conventional methods use bioassay-guided separation
techniques to identify bioactives. Natural -glucosidase
inhibitors have been screened using in vitro enzy-
matic assays, followed by time-consuming isolation
of the active compounds [21, 22]. In recent years, mass
spectrometry-based assays have attracted great atten-
tion for high-throughput screening. These methods,
which include quantitative MALDI-FT-MS [23], enzyme
affinity selection procedure followed by ESI-FT-MS [24],
frontal affinity chromatography-MS [25], size-exclusion
chromatography-MS [26], capillary electrophoresis-MS
[27], and pulsed-ultrafiltration MS [28–30], all have been
successfully used to determine potentially active com-
pounds. Ultrafiltration LC-MS/MS is a powerful tool to
screen biologically active compounds from botanical ex-
tracts because of its high throughput on-line screening
ability, and its high sensitivity and selectivity necessary
for the characterization of compounds present at low
concentrations in highly complex matrices without
time-consuming purification procedures [28–30].
In the present paper, we used an in vitro model to
examine the inhibitory activity of HLFE on -glucosidase,
and then ultrafiltration LC-MS to screen the ligands
of -glucosidase. As a result, four compounds with
-glucosidase inhibitory effects were observed and iden-
tified by on line LC-DAD-MSn analysis, and their identities
were further confirmed to be quercertin-3-O-rhamnosyl-
(1-4)-glcosylrhamnoside, vitexin-2“-O-glucoside, vitexin-
2”-O-rhamnoside, and vitexin by accurate mass data
taken at high mass resolving power with an FT-MS.
Because three of the four -glucosidase inhibitors were
C-glycosylflavones, additional C-glycosylflavones (vi-
texin, isovitexin, orientin, isooriention) and their proto-
typal compounds, apigenin, and luteolin were tested, and
found to be strong -glucosidase inhibitors as well, par-
ticularly those with a hydroxy substituent at C-3=.
Experimental
Materials
The HLFE was purchased from Xi’an Acetar Biology
and Technology Co., Ltd. (Xi’an, China) with total
flavones 40%. Standard apigenin, vitexin, quercetin,and luteolin were purchased from the National Institute
for the Control of Pharmaceutical and Biological Prod-
ucts (Beijing, China), and isovitexin and orientin were
purchased from Shanghai Tauto Biotech Co., Ltd.
(Shanghai, China). Isoorientin was from Beijing Seajet
Scientific Co., Ltd. (Beijing, China), and -glucosidase
(E.C. 3.2.1.20) from yeast was purchased from Fluka
(Bueke, Switzerland). Acetonitrile was of HPLC grade
from Fisher Scientific (Loughborough, UK); acetic acid
was HPLC grade from TEDIA (Fairfield, OH); water
was purified in-house using a Milli-Q water purifica-
tion system (Milford, MA). Solvents and all other chem-
icals, otherwise not mentioned, were purchased from
Beijing Shiji (Beijing, China).
Methods
-Glucosidase Inhibition Assay
The enzyme inhibition studies were carried out spec-
trophotometrically in a 96-well microplate reader using
a procedure reported by Li et al. [31]. A total 60 L
reaction mixture containing 20 L of 100 mM phos-
phate buffer (pH 6.8), 20 L of 2.5 mM p-nitrophenyl
-D-glucopyranoside (PNP-G) (Biochem) in the buffer,
and 20 L of standard flavonoid in 50% methanol
were added to each well, followed by 20 L of 10 mM
phosphate buffer (pH 6.8) containing 0.2 U/mL -
glucosidase to the mixture of treatment terminated
wells. The plate was incubated at 37 °C for 15 min, and
then adding 80 L of 0.2 mol/L sodium carbonate
solution to stop the reaction. Right after that, absor-
bance was recorded at 405 nm with a Tecan GENios
multifunctional microplate reader (Männedorf, Switzer-
land). Controls contained the same reaction mixture
except the same volume of phosphate buffer was added
instead of a flavonoid solution. Acarbose (Bayer) was
dissolved in water and used as a positive control. The
inhibition (%) was calculated as: (A1  A2)/A1100%,
where A1 is the absorbance of the control, and A2, the
absorbance of the sample.
Screening by Ultrafiltration LC-MS
One L of 20 mg/mL HLFE sample solution was
incubated for 0.5 h at 37 °C with 4 L of 250 M
-glucosidase in 10 mM ammonium acetate buffer (pH
6.86), in a total volume of 100 L. After incubation, each
mixture was filtered through a Microcon (Millipore,
Bedford, MA) YM-10 centrifugal filter containing a
regenerated cellulose ultrafiltration membrane with a
10,000 MW cutoff by centrifugation at 10,000 g for 10
min at room temperature. The filter was washed three
times to remove the unbound compounds by centrifu-
gation with 100 L aliquots of ammonium acetate
buffer (pH 6.86) at room temperature. The bound li-
gands were released by adding 100 L of methanol/
water (50:50; vol/vol) (pH 3.30) followed by centrifu-
gation at 10,000 g for 15 min; this process was repeated
1498 LI ET AL. J Am Soc Mass Spectrom 2009, 20, 1496–1503three times. The solvent in the ultrafiltrates were re-
moved under vacuum, and the released ligands were
used for LC-MS analysis. A control experiment in which
enzyme omitted was also carried out before each
screening experiment.
LC-MSn
The released ligands were redissolved in 40 L of
methanol/water (50:50; vol/vol). Aliquots (20 L) of
this reconstituted ligand solution were analyzed using
LC-MS, which consisted of a Waters (Milford, MA) 2690
HPLC system coupled to an ion trap mass spectrometer
with an electrospray ionization interface (Finnigan
MAT, San Jose, CA). HPLC separations were carried
out using a C18 column (150 mm  4.6 mm, 5 m,
Dikma, Beijing, China) and a C18 guard column
(Dikma). The column temperature was kept at 25 °C.
The flow rate was set to 0.5 mL/min and the eluting
gradient was as follows: [acetonitrile (A) and 0.5%
acetic acid in water (B)]: 0–10 min, 20% A; 10–15 min,
20%–30% A; 15–20 min, 30% A. The mass spectrometer
was operated in the negative ion mode with source
voltage of 5.0 kV. The metal capillary voltage was set to
4.5 V and temperature at 250 °C, the sheath gas (N2)
flow-rate was 50 arb, the scan range was m/z 100–1500
Da; the maximum injection time was 200 ms.
SORI-CID FTICR MS
The HLFE was diluted into proper concentration, and
then introduced to the IonSpec (Irvine, CA) 7.0 T FTICR
mass spectrometer with a Waters Z-spray source. The
capillary voltage was set at 3.5 kV. The ions were
accumulated for 1.5 s in a hexapole ion guide. After
accumulation, the ions were transferred to the ICR
cell. The operating software was IonSpec99 version
7.5.10.64. All acquisitions were performed on a 1024 K
dataset and 1 scan. During detection, a broad band
analysis mode was used in the mass range of m/z
108–1500 Da, source temperature of 100 °C, and probe
temperature of 80 °C. Tandem mass spectra were ob-
tained by sustained off resonance irradiation (SORI)
CID with nitrogen as collision gas after isolation of the
appropriate precursor ions (1 Da); 100 ms N2 was
added as collision gas.
Results and Discussion
-Glucosidase Inhibitors in HLFE by an In Vitro
Enzyme Assay and Ultrafiltration LC-DAD-MS
The in vitro -glucosidase assay was conducted as a
prescreening of the activity for the high-throughput
ultrafiltration LC-MS based assay. The enzyme inhibi-
tion assay showed that the HLFE inhibited 86% of the
enzyme activity at 25 g/mL, significantly higher than
that of the well known synthetic -glucosidase inhibi-
tor, acarbose (63.90% inhibition at 250 g/mL) (Table1). The -glucosidase inhibitory activity of HLFE was
further confirmed by ultrafiltration LC-DAD-MS, which
also provided enzyme inhibition activities of individual
flavonoids present in the extract.
The ultrafiltration LC-MS screening is an affinity
screening method based on MS. When a mixture of
compounds is injected into the ultrafiltration chamber
containing a macromolecular receptor, in our study,
-glucosidase, the ultrafiltration membrane retains the
macromolecules and the ligand–receptor complexes but
allows unbound, low molecular weight compounds to
elute from the chamber. In this manner, the ultrafiltra-
tion chamber functions as a solution-phase extraction
device, retaining ligands that can tightly bind to a recep-
tor, e.g., -glucosidase, while unbound compounds will
be washed away. After that, the ligand–receptor com-
plex is disrupted by addition of organic solvent or
changing pH value, and then the released ligands can
be identified by LC-MS analysis [29].
The receptor and ligand concentrations also deter-
mine the number of “hits” that might be obtained, so
incubation of equimolar concentrations of the hawthorn
leaf flavonoids were carried out at three different con-
centrations of -glucosidase (5, 10, and 20 M). After
incubation with -glucosidase and ultrafiltration affin-
ity purification, the trapped ligands originally from the
HLFE were analyzed by LC-DAD-MS. The LC-MS
spectra for this experiment are shown in Figure 1. At 5
M -glucosidase, only two components, eluting at 8.43
and 10.03 min, showed binding affinity to the receptor,
-glucosidase (see Figure 1a). However, when the
-glucosidase concentrations were increased to 10 and
20 M, up to four ligands were observed (Figure 1b and
1c). Moreover, the amount of ligands bound to the
enzyme (receptor) was also found to be greater at
increased -glucosidase concentrations (Figure 1b and
1c). Higher receptor concentrations typically result in
larger numbers of hits because weaker ligands can also
be identified together with the high-affinity compounds
[28]. Botanical extracts usually contain multiple ligands;
therefore excess receptor is required to minimize the
competition between ligands of different affinities, and
Table 1. Inhibition activity of flavones against a-glucosidase
Samples Inhibitiona,b (%) IC50 (M)
a,e
HLFE 89.86c 7.1 g/mL
Acarbose 63.90d 228.16
Apigenin 46.22 21.85
Vitexin 19.91 25.11
Isovitexin 30.20 23.26
Luteolin 60.42 13.07
Orientin 38.22 23.30
Isoorientin 47.72 19.68
aThe result was an average of three determinations.
bInhibition by 25 M flavone.
cInhibition by 25 g/mL HLFE.
dInhibition by 250 g/mL acarbose, namely 387.5 M.
eConcentration required for 50% inhibition of the enzyme activity under
the assay conditions.to detect more potential ligands.
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max at around 254 and 353 nm, while Compounds 2, 3,
and 4 had nearly the same UV spectra with their max at
around 267 and 335 nm, indicating Compounds 2–4
were structurally similar but different from Compound
Figure 1. Ultrafiltration LC-MS screening of HLFE for binding to
-glucosidase.Figure 2. MSn spectra of Compoun1. The negative ion ESI-MS produced deprotonated ions
of Compounds 1–4 at m/z 755 (tR  6.27 min), 593 (tR 
8.43 min), 577 (tR 10.03 min), and 431 (tR 12.28 min),
respectively. These compounds (ligands) were identi-
fied by LC-MSn and SORI-CID FTICR MS.
Structural Characterization of -Glucosidase
Inhibitors from HLFE by LC-MSn and SORI-CID
FTICR MS
LC-MSn and SORI-CID FTICR MS experiments were
both carried out to identify compounds that bound to
-glucosidase in the enzyme and ultrafiltration LC-MS
assays. The main fragment ions were m/z 609, 591, 489,
300, and 301 in the MS2 spectrum of Compound 1, as
shown in Figure 2a. The two ions at m/z 300 and 301
suggested that Compound 1 might contain a quercetin
(MW 302) skeleton, and this observation was confirmed
by matching the tandemMS spectra of the ion atm/z 301
with those of the standard quercetin (data not shown).
The [M  H  146] ion at m/z 609 and the [M  H 
164] ion at m/z 591 were suggestive of a deoxyhexose
residue presents at the terminal site of a sugar chain.
Detailed fragmentation ions and their relationships
with the molecular structure of each compound were
analyzed by high-resolution SORI CID, and listed in
Table 2. Ablajan et al. [32] reported an elaborate MS
study on a series of flavonoid compounds with a
quercetin skeleton. Based on their results, different
glycosylation positions can significantly affect the frag-
mentation patterns of quercetin glycosides in the nega-d 1 in the negative ion mode.
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1500 LI ET AL. J Am Soc Mass Spectrom 2009, 20, 1496–1503tive ion mode. Quercetin C-3=-O-glycoside only gives a
product ion at m/z 301; quercetin C-3-O-glycoside gives
product ions of m/z 300 and 301, both of which had high
relative abundance. However, for quercetin C-7-O-
glycoside, while these two ions (m/z 300 and 301) were
still detected, the relative abundance of the ion m/z 300
was markedly lower than that of the ion m/z 301. We
therefore concluded that the oligosaccharide chain of
Compound 1 is likely linked at the C-3 position because
of the high relatively abundance of the two aforemen-
tioned ions (Figure 2a). As shown in Figure 2a, the
[M  H  146  120] ion of m/z 489 indicates that the
deoxyhexose unit is linked to the hexose residue, and
the neutral loss of 120 Da corresponds to the cross-ring
cleavage of the hexose at 0,2 position. In theMS3 spectrum
of the ion m/z 489 (Figure 2b), fragment ions of m/z 343,
325, and 281 are detected with neutral losses of 146,
164, and 208 Da, respectively. The neutral losses of
146 and 164 Da indicate the existence of an additional
deoxyhexose. The trisaccharide moiety in Compound
1 containing one hexose and two deoxyhexoses is consid-
ered to be linked as follows: deoxyhexose–hexose–
deoxyhexose. The MS3 experiment of ion m/z 591 was
also performed, and the data are shown in Figure 2c.
The base peak of m/z 355 corresponds to the cross-ring
cleavage of the deoxyhexose moiety at 0,3 site along
with loss of a molecular H2O. This result further proves
the linear linkage of the trisaccharide moiety. The
cross-ring cleavage of the deoxyhexose moiety at 0,3 site
also suggests that the linkage of between the deoxyhex-
ose to hexose is a 1–4 linkage. The linkage between the
hexose residue and the terminal deoxyhexose moiety
could not be determined because of lack of a similar
cleavage at the 0,2 site. As glucose and rhamnose are the
Table 2. Accurate product ions mass data of Compounds 1 to 4
Measured m/z Fragment ions Theory
Compound 1
755.20581 [MH] 755.204
489.10254 0,2X1
 489.103
343.04625 0,2X0
 343.045
301.03566 Y0
 301.035
300.02786 Y0
–H 300.027
271.02505 Y0
–CH2O 271.024
255.03031 Y0
–CO–H2O 255.029
Compound 2
593.15032 [MH] 593.151
413.08676 Z1
 413.087
293.04458 0,2X0Z1
 293.045
Compound 3
577.15455 [MH] 577.156
457.11304 0,2X0
 457.114
413.08589 Z1
 413.087
311.05496 311.056
293.04440 0,2X0Z1
 293.045
Compound 4
431.09864 [MH] 431.098
311.05673 0,2X0
 311.056
283.06189 0,2X0
–H2O 283.061main types of hexose and deoxyhexose in hawthornleaves [12], respectively, we have tentatively given the
identity of Compound 1 as quercetin-3-O-rha- (1–4)-
glc-rha [18], and the structure is shown in Figure 2.
Compound 4 (tR  12.18 min) was identified as
vitexin by comparing mass spectra and the fragmenta-
tion pattern with those of the standard. In the MS2
spectrum of deprotonated vitexin, only two product
ions were observed, 0,2X0
 ion of m/z 311 and 0,3X0
 ion
of m/z 341, both are considered to originate from the
cross-ring cleavage of the glucose residue by losing
C4H8O4 (120 Da) and C3H6O3 (90 Da), respectively
(Figure 3a and Table 2). All of these data matched those
of vitexin. The spectra were simpler because vitexin
contains a C-glycoside bond that is less readily cleaved.
The only product ions detected were those from the
cross-ring cleavage (Figure 3).
Compounds 2 and 3 have similar UV absorbance as
Compound 4, which indicates they both possess the
vitexin skeleton. This conclusion was supported by the
following MSn data. As shown in Figure 4a and Table 2,
the [M  H] ion m/z 593 of Compound 2 produced a
base peak ion of m/z 413 (Z1
) by losing 180 Da,
suggesting the presence of a hexose moiety, and the ion
m/z 413 matched the dehydrated vitexin ion. In addi-
tion, a minor product ion ofm/z 473 (0,2X) by losing 120
Da from the [MH] ion, demonstrates the cleavage of
the hexose ring at 0,2 position (Figure 4a), more impor-
tantly, the linkage of hexose residue to hexose residue is
at the 1–2 position. MS3 experiments of ions of m/z 413
and 473 were further performed (Figure 4b and 4c). In
the MS3 spectrum of ion of m/z 413, the product ion m/z
293 (0,2XZ1
) was from losing 120Da due to the cleavage
at the 0,2 site of the hexose residue. MS3 of m/z 473
produced m/z 311 as a result of a neutral loss of 162 Da,
Formula element [MH] Error (ppm)
C33H40O20
1 2.37
C23H22O12
1 2.68
C17H12O8
1 0.90
C15H9O7
1 0.93
C15H8O7
1 1.03
C14H7O6
1 0.86
C14H7O5
1 1.61
C27H29O15
1 1.48
C21H17O9
1 2.54
C17H9O5
1 3.31
C27H29O14
1 3.00
C23H22O10
1 2.14
C21H17O9
1 4.65
C17H11O6
1 3.70
C17H9O5
1 3.92
C21H19O10
1 0.63
C17H11O6
1 2.64
C16H11O5
1 2.44m/z
02
85
94
38
55
81
90
19
81
55
28
02
81
11
55
37
11further suggesting the existence of a hexose unit in
poun
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vitexin-2“-O-glucoside [19].
MS2 of the [M  H] ion (m/z 577) of Compound 3
produced m/z 413 (Z1
), which matched the loss of a
deoxyhexose unit (Figure 5a and Table 2). The ion m/z
457 (0,2X0
) was a result of the cross-ring cleavage of the
hexose moiety at 0,2, indicating the linkage between
this hexose and the deoxyhexose to be at the 1–2 site.
The ion of m/z 413 gave rise to the fragment ion m/z 293
in the MS3 experiment (Figure 5b), and the latter [m/z
293 (0,2X0Z1
)] was similarly suggestive of the cross-
ring cleavage at 0,2 site as discussed above. In addition,
the MS3 experiment of the 0, 2X0
 ion (m/z 457) produced
the base peak ion m/z 311 (Figure 5c), further confirm-
Figure 3. MSn spectra of ComFigure 4. MSn spectra of Compouning the existence of a deoxyhexose moiety. Compound
3 can be identified as vitexin-2”-rhamnoside [19].
-Glucosidase Inhibition Assay
Recent studies have shown that the intake of quercetin
was inversely associated with the risk of incident type 2
diabetes. Isoquercitrin, isorhamnetine-3-O-rutinoside,
and a C-glycosylate apigenin derivative vitexin have also
been reported to have strong inhibitory activities against
-glucosidase [14, 15]. Our screening results confirmed
that quercetin and vitexin and their glycosides, represent-
ing flavonols and flavones, are -glucosidase inhibitors
(Figure 1). C-glycosylflavones such as vitexin have been
d 4 in the negative ion mode.d 2 in the negative ion mode.
poun
1502 LI ET AL. J Am Soc Mass Spectrom 2009, 20, 1496–1503reported to have antioxidant, anti-virus, liver protec-
tion, and other activities [20], however, the inhibitory
activities of C-glycosylflavones on -glucosidase have
rarely been reported. On the other hand, apigenin and
luteolin are the two main flavone aglycones in haw-
thorn, and the only difference between them was the
extra hydroxyl group at the C-3= position (R3) for
luteolin (Figure 6). Vitexin and isovitexin are the corre-
sponding C-6 and C-8 C-glycosylflavones of apigenin,
respectively, and orientin and isoorientin are the C-6
and C-8 C-glycosylflavones of luteolin, respectively
(Figure 6). We therefore tested these C-glycosylflavones
(vitexin, isovitexin, orientin, and isoorientin) and their
aglycones apigenin and luteolin for their -glucosidase
inhibitory activities.
Figure 5. MSn spectra of ComFigure 6. Structures of flavones studied by an in vitro assay.Table 1 shows the -glucosidase inhibition rates (%)
of the above mentioned flavone aglycones and their
C-glycosylated derivatives (at 25 M) and their IC50
values. All of the six tested compounds showed higher
-glucosidase inhibitory activity than acarbose, one of
the most potent -glucosidase inhibitor drugs. The
inhibitory activity decreased in the following order:
luteolin  isoorientin  apigenin  orientin  isovi-
texin  vitexin (Table 1). Flavones with a hydroxyl
group at C-3= possessed stronger inhibition than the
corresponding flavones without a C-3= hydroxyl group,
namely, luteolin  apigenin, orientin  vitexin, and
isoorientin  isovitexin. The C-3= hydroxylation of the
B-ring apparently plays an important part in the -
glucosidase inhibitory activity of flavones. Moreover,
the aglycones showed stronger activity than their respec-
tive C-glycosylated derivatives: the inhibition rate fol-
lowed the order of luteolin  isoorientin  orientin for
luteolin derivatives; and similarly, apigenin  isovi-
texin  vitexin for apigenin derivatives. Glycosylation
at C-6 or C-8 weakens the inhibitory activity of flavones
against -glucosidase, although the C-6 glycosylation
had relatively less impact than the C-8 glycosylation, as
the inhibition rates were isovitexin vitexin and isoori-
entin  orientin (Table 1). Similar results have been
reported elsewhere by Tadera et al.: hydroxylations at
the C-3 and C-5 positions on the A and C rings of
flavones enhance the inhibitory activity, but for the B
ring of flavones, C-4=-OH is crucial for the inhibitory
activity, C-3=-OH and C-5=-OH are favorable to the
inhibitory activity [33]; 5,6,7-trihydroxyflavone struc-
d 3 in the negative ion mode.ture is crucial for the potent inhibitory activity, while
1503J Am Soc Mass Spectrom 2009, 20, 1496–1503 -GLUCOSIDASE BY ULTRAFILTRATION LC-DAD-MSnC-8 substituted flavone derivatives tend to decrease the
inhibitory activity [34].
Conclusions
The ultrafiltration LC-DAD-MSn method reported above
is a valuable tool for effective screening of and iden-
tifying anti--glucosidase compounds in complex sam-
ples such as HLFE compared with the commonly used
bioassay-guided column separation techniques. It is a
high throughput assay technique that can significantly
reduce the time, effort, and other resources than con-
ventional approaches. Using accurate mass spectrome-
try and multistage tandem mass spectrometry data,
ligands bound to the enzyme (-glucosidase) were
identified as quercertin-3-O-rha-(1–4)-glc-rha, vitexin-
2“-O-glucoside, vitexin-2”-O-rhamnoside, and vitexin.
Based on the activities of these ligands, similar C-
glycosylflavones and corresponding aglycones were
evaluated using in vitro assays, and their inhibitory
activity toward -glucosidase was validated. The 5,7,4=-
trihydroxyflavone structure, such as in apigenin and lu-
teolin derivatives, was crucial for the inhibitory activity;
but an additional C-3=-OH substitute on the B-ring en-
hanced the activity. On the other hand, C-glycosylations
at C-6 or C-8 weakened the inhibition. Our results and
findings by others, such as the aldose reductase inhib-
itory activity of luteolin, apigenin, quercetin, and a
series of corresponding glycosides [35], suggest that
hawthorn leaf, a herbal medicine containing different
types of flavonoids, may contain an important group of
candidates as natural anti-type 2 diabetes drugs that
warrant further investigation.
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